When facing a terminal illness, hope begins to fade rather quickly. The chances of something working requires great faith or in some cases - a what have I got to lose at this point, attitude. For some patients who were given the "there's nothing more that we can do," they enrolled in the clinical trial program at New York City's Memorial Sloan Kettering Cancer Center and the results for some were remarkable. Can you imagine the largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells? Well, here's the journey of Paolo Cavalli.
While each journey is unique, we all share a common theme - cancer changes our lives forever.